Management of Breakthrough Bleeding in IUD Users

Initial Assessment and Treatment

The Centers for Disease Control and Prevention recommends ruling out underlying gynecological problems such as IUD displacement, STDs, pregnancy, or pathologic uterine conditions before initiating treatment for breakthrough bleeding 3
Proper IUD placement should be verified by checking for the presence of IUD strings, as recommended by the Centers for Disease Control and Prevention 1
Unscheduled spotting or light bleeding is expected during the first 3-6 months of LNG-IUD use and generally decreases with continued use, according to the Centers for Disease Control and Prevention 4

The American College of Obstetricians and Gynecologists recommends NSAIDs for 5-7 days as first-line treatment for breakthrough bleeding in IUD users 1, 2
For LNG-IUD users, hormonal treatment with combined oral contraceptives (COCs) or estrogen for 10-20 days can be added if NSAIDs are ineffective, as recommended by the Centers for Disease Control and Prevention 1, 2

Treatment should be initiated when breakthrough bleeding occurs and persists beyond the expected adjustment period (3-6 months), according to the Centers for Disease Control and Prevention 4, 3
Patients should be counseled that bleeding irregularities are common with IUD use, especially in the first 3-6 months, and generally decrease over time, as recommended by the Centers for Disease Control and Prevention 4, 3
With LNG-IUD use, approximately half of users experience amenorrhea or oligomenorrhea by 2 years, according to the Centers for Disease Control and Prevention 4

Alternative methods should be considered if bleeding persists despite treatment and the woman finds it unacceptable, as recommended by the Centers for Disease Control and Prevention 1, 2
Underlying pathology that warrants IUD removal should be identified, according to the Centers for Disease Control and Prevention 3